Cite
HARVARD Citation
Koltun, D. et al. (2016). Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic & medicinal chemistry letters. 26 (13), pp. 3202-3206. [Online].